Intuitive Surgical reported Q1 2026 revenue of $2.77 billion and adjusted EPS of $2.50, both surpassing analyst expectations. The company raised its 2026 Da Vinci procedure growth forecast to 13.5%-15.5%, driven by strong U.S. and international demand despite some weakness in Asia. Challenges include U.S. insurance changes, European economic constraints, and competitive pressures. The stock gained over 2% in premarket trading following the positive results and outlook upgrades.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
